Cowen Starts Radius Health (RDUS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to Cowen Starts Radius Health (RDUS) at Outperform
July 16, 2014 7:30 AM EDT
Canaccord Genuity initiated coverage on Radius Health (NASDAQ: RDUS) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Radius Health click here. For more ratings news on Radius Health click here.
Shares of Radius Health closed at $12.14 yesterday.
...
More
July 16, 2014 7:23 AM EDT
Jefferies initiates coverage on Radius Health (NASDAQ: RDUS) with a Buy rating and a price target of $17.00.
Analyst Eun K. Yang, Ph.D. said, "Ahead of Ph3 data in 12/14, we view highly likely Ph3 success for abaloparatide-SC in osteoporosis (achieving primary endpoint of... More
July 16, 2014 6:52 AM EDT
Cantor Fitzgerald initiates coverage on Radius Health (NASDAQ: RDUS) with a Buy rating and a price target of $20.00.
Analyst Mara Goldstein said, " We like the simplicity of the company's value proposition: a late stage asset with near-term revenue potential, with the potential... More
